Norma Nowak, director of science and technology for UB's New York State Center of Excellence in Bioinformatics and Life Sciences, described the latest advances of her lab in characterizing ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
Accurate classification of tissue samples is an essential tool in disease diagnosis and treatment. The DNA microarray technology enables disease classification based only on gene expression analysis, ...
- The United States Biomedical Advanced Research and Development Authority (BARDA) has announced Vaxxas will receive US$2 million (AU$3.2 million) as a Concept Stage Winner in its multi-stage $50 ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback